Dogwood Therapeutics Announces First Quarter 2026 Financial Results
PRESS RELEASE - Thu, 14 May 2026 16:42:40

— Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026 —
— FDA acceptance of SP16 Investigational New Drug Application for the treatment of Chemotherapy Induced Pain and Neuropathy —
— Announces Worldwide Development and Commercialization Partnership for Legacy Antiviral Assets with potential value up to $100M to Dogwood and its current and former shareholders —
Edye Welcomes Stomp! Stomp! Rhinos! to Its Growing Preschool Lineup
PRESS RELEASE - Wed, 13 May 2026 18:31:17

— The beloved emotional wellness franchise from OAK9 joins HITN's Spanish-language platform for US and Latin American audiences —
— Stomp! Stomp! Rhinos! follows Rhino siblings Noah, Ela, and Ron as they navigate everyday preschool experiences, learning to understand and manage big emotions through storytelling, music, and playful mindfulness —
« Previous Next »
2.0.2